Dual PI3K/AKT/mTOR Inhibitor BEZ235 synergistically enhances the activity of JAK2 inhibitor against cultured and primary human myeloproliferative neoplasm cells
Warren Fiskus, Srdan Verstovsek, Taghi Manshouri, Jacqueline E. Smith, Karissa Peth, Sunil Abhyankar, Joseph McGuirk, Kapil N. Bhalla
Dive into the research topics of 'Dual PI3K/AKT/mTOR Inhibitor BEZ235 synergistically enhances the activity of JAK2 inhibitor against cultured and primary human myeloproliferative neoplasm cells'. Together they form a unique fingerprint.